Day: April 7, 2026

Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy

Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension

WILMINGTON, Del., April 07, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company...

Red Light Holland Reports Continued Expansion of Filament Health’s PEX010 Clinical Network with New License Agreements and Research Shipments

Three new license agreements signed and two research shipments completed in March 2026, spanning institutions in Australia, the United Kingdom,...

error: Content is protected !!